The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2015
Filed:
Aug. 15, 2008
Peter Madsen, Bagsværd, DK;
Thomas Børglum Kjeldsen, Virum, DK;
Thomas Hoeg-jensen, Klampenborg, DK;
Tina Møller Tagmose, Ballerup, DK;
Palle Jakobsen, Værløse, DK;
János Tibor Kodra, København Ø, DK;
Patrick William Garibay, Holte, DK;
Dorte Xenia Gram, København Ø, DK;
Peter Madsen, Bagsværd, DK;
Thomas Børglum Kjeldsen, Virum, DK;
Thomas Hoeg-Jensen, Klampenborg, DK;
Tina Møller Tagmose, Ballerup, DK;
Palle Jakobsen, Værløse, DK;
János Tibor Kodra, København Ø, DK;
Patrick William Garibay, Holte, DK;
Dorte Xenia Gram, København Ø, DK;
Novo Nordisk A/S, Bagsvaerd, DK;
Abstract
An acylated insulin analogue wherein the insulin analogue comprises a lysine residue connected C-terminally to the A21 amino acid residue or a peptide residue of up to 4 amino acid residues comprising a lysine residue which peptide residue is connected C-terminally to the A21 amino acid residue, characterized in that an acyl moiety comprising an alkylene glycol moiety is attached to the lysine residue in the A22 position or attached to a lysine residue present in the peptide residue that is attached to the C terminal end of the A21 amino acid residue and wherein there is only one lysine (K, Lys) in the insulin analogue, can conveniently be administered pulmonary.